Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of EXE844 (Finafloxacin) in Pediatric Subjects Following Tympanostomy Tube Surgery
NCT02539654Phase 1Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of finafloxacin in otitis media with effusion (OME) and acute otitis media (AOM), sponsored by Alcon Inc. Primary endpoints: Maximum Analyte Plasma Concentration at Day 1, Time to Reach Maximum Concentration at Day 1 and 4 more. Started Nov 2015; status: completed.
02
Drugs
finafloxacin
03
Conditions
otitis media with effusion (OME)acute otitis media (AOM)
Beyond the preview
Go deeper on NCT02539654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539654.